Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Acellular Adipose Tissue (AAT) in Healthy Volunteers
NCT02817984Phase 1Completed
- Sponsor
- Johns Hopkins University
- Start
- Apr 2016
- Primary completion
- Apr 2017
- Modality
- Injectable Hydrogels, Implantable Devices, Implantable Hydrogels
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of acellular adipose tissue in soft tissue defect, sponsored by Johns Hopkins University. Primary endpoints: Incidence of adverse events at 12 weeks and Rate of adverse events at 12 weeks. Started Apr 2016; status: completed.
02
Drugs
acellular adipose tissue
03
Conditions
soft tissue defect
Beyond the preview
Go deeper on NCT02817984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02817984.